A Study to Evaluate MWN109 Injection in Healthy Subjects

NCT06859853 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obese

Interventions

DRUG: Placebo
DRUG: Subcutaneous single and mutiple dose

Sponsor

Shanghai Minwei Biotechnology Co., Ltd